BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol. 2005;20:1691-1695. [PMID: 16246187 DOI: 10.1111/j.1440-1746.2005.03905.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Mojtahedi Z. Possible different serum IL-4 levels across populations: A reason for dissimilar incidence of Th1 and Th2 diseases. Medical Hypotheses 2012;78:776-7. [DOI: 10.1016/j.mehy.2012.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Al-Qabandi WA, Buhamrah EK, Hamadi KA, Al-Osaimi SA, Al-Ruwayeh AA, Madda J. Inflammatory bowel disease in children, an evolving problem in Kuwait. Saudi J Gastroenterol. 2011;17:323-327. [PMID: 21912059 DOI: 10.4103/1319-3767.84487] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
3 Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV, Tysk C, O’Morain C, Moum B, Colombel JF. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62:630-649. [PMID: 23335431 DOI: 10.1007/s11894-013-0313-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
4 Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge. Am J Gastroenterol 2009;104:1003-12. [PMID: 19240705 DOI: 10.1038/ajg.2008.162] [Cited by in Crossref: 134] [Cited by in F6Publishing: 118] [Article Influence: 10.3] [Reference Citation Analysis]
5 Siddique I, Alazmi W, Al-ali J, Longenecker JC, Al-fadli A, Hasan F, Memon A. Demography and clinical course of ulcerative colitis in Arabs – a study based on the Montreal classification. Scandinavian Journal of Gastroenterology 2014;49:1432-40. [DOI: 10.3109/00365521.2014.966318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Torki M, Gholamrezaei A, Mirbagher L, Danesh M, Kheiri S, Emami MH. Vitamin D Deficiency Associated with Disease Activity in Patients with Inflammatory Bowel Diseases. Dig Dis Sci 2015;60:3085-91. [PMID: 26031421 DOI: 10.1007/s10620-015-3727-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
7 Yamamoto-furusho JK. Clinical Epidemiology of Ulcerative Colitis in Mexico: A Single Hospital-based Study in a 20-year Period (1987-2006). Journal of Clinical Gastroenterology 2009;43:221-4. [DOI: 10.1097/mcg.0b013e31817a76b4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
8 Kedia S, Ahuja V. Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East. Inflamm Intest Dis. 2017;2:102-115. [PMID: 30018961 DOI: 10.1159/000465522] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 8.6] [Reference Citation Analysis]
9 Liasis L, Papaconstantinou HT, Tierris I, Clark CC. Ulcerative colitis in patient with sickle cell disease: A conspiracy of nature that turns surgeon’s decision into a challenge. Hellenic J Surg 2013;85:55-7. [DOI: 10.1007/s13126-013-0008-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Fadda MA, Peedikayil MC, Kagevi I, Kahtani KA, Ben AA, Al HI, Sohaibani FA, Quaiz MA, Abdulla M, Khan MQ, Helmy A. Inflammatory bowel disease in Saudi Arabia: a hospital-based clinical study of 312 patients. Ann Saudi Med. 2012;32:276-282. [PMID: 22588439 DOI: 10.5144/0256-4947.2012.276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
11 Fadda MA, Peedikayil MC, Kagevi I, Kahtani KA, Ben AA, Al HI, Sohaibani FA, Quaiz MA, Abdulla M, Khan MQ. Inflammatory bowel disease in Saudi Arabia: a hospital-based clinical study of 312 patients. Ann Saudi Med. 2012;32:276-282. [PMID: 22588439 DOI: 10.5144/0256-4947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
12 Gholamniya Foumani M, Sadeghi N, Dehghanzadeh S; 1 Community Health Research Center, Isfahan (Khorasgan) Branch, Islamic Azad University, Isfahan, Iran, 2 Nursing Department, Nursing and Midwifery Faculty, Rasht branch, Islamic Azad University, Rasht, Iran. . AIMS Medical Science 2019;6:218-29. [DOI: 10.3934/medsci.2019.3.218] [Reference Citation Analysis]
13 Alharbi OR, Azzam NA, Almalki AS, Almadi MA, Alswat KA, Sadaf N, Aljebreen AM. Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification. World J Gastroenterol 2014; 20(46): 17525-17531 [PMID: 25516667 DOI: 10.3748/wjg.v20.i46.17525] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
14 Economou M, Pappas G. New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis 2008;14:709-20. [PMID: 18095316 DOI: 10.1002/ibd.20352] [Cited by in Crossref: 125] [Cited by in F6Publishing: 119] [Article Influence: 8.9] [Reference Citation Analysis]
15 Sands BE, Siegel CA. Crohn's Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 1941-1973.e9. [DOI: 10.1016/b978-1-4160-6189-2.00111-6] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
16 Firouzi F, Rashidi M, Hashemi S, Kangavari M, Bahari A, Daryani NE, Emam MM, Naderi N, Shalmani HM, Farnood A, Zali M. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software. Eur J Gastroenterol Hepatol 2007;19:1075-81. [PMID: 17998832 DOI: 10.1097/MEG.0b013e3282202bb8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
17 Ott C, Takses A, Obermeier F, Schnoy E, Müller M. Smoking increases the risk of extraintestinal manifestations in Crohn's disease. World J Gastroenterol 2014; 20(34): 12269-12276 [PMID: 25232261 DOI: 10.3748/wjg.v20.i34.12269] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
18 Shadnoush M, Hosseini RS, Khalilnezhad A, Navai L, Goudarzi H, Vaezjalali M. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. Korean J Gastroenterol. 2015;65:215-221. [PMID: 25896155 DOI: 10.4166/kjg.2015.65.4.215] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
19 Srinath AI, Goyal A, Zimmerman LA, Newara MC, Kirshner MA, McCarthy FN, Keljo D, Binion D, Bousvaros A, DeMaso DR. Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients. Inflamm Bowel Dis. 2014;20:1329-1340. [PMID: 24983975 DOI: 10.1097/mib.0000000000000104] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Zamani S, Zali MR, Aghdaei HA, Sechi LA, Niegowska M, Caggiu E, Keshavarz R, Mosavari N, Feizabadi MM. Mycobacterium avium subsp. paratuberculosis and associated risk factors for inflammatory bowel disease in Iranian patients. Gut Pathog 2017;9:1. [PMID: 28053669 DOI: 10.1186/s13099-016-0151-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
21 Ghavami SB, Rostami E, Sephay AA, Shahrokh S, Balaii H, Aghdaei HA, Zali MR. Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases. Microbial Pathogenesis 2018;117:285-9. [DOI: 10.1016/j.micpath.2018.01.029] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
22 Sairenji T, Collins KL, Evans DV. An Update on Inflammatory Bowel Disease. Prim Care. 2017;44:673-692. [PMID: 29132528 DOI: 10.1016/j.pop.2017.07.010] [Cited by in Crossref: 127] [Cited by in F6Publishing: 105] [Article Influence: 25.4] [Reference Citation Analysis]
23 Alireza Taghavi S, Reza Safarpour A, Hosseini SV, Noroozi H, Safarpour M, Rahimikazerooni S. Epidemiology of Inflammatory Bowel Diseases (IBD) in Iran: A Review of 740 Patients in Fars Province, Southern Iran. Ann Colorectal Res 2013;1:17-22. [DOI: 10.17795/acr-11477] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
24 Bielefeldt K, Davis B, Binion DG. Pain and inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:778-788. [PMID: 19130619 DOI: 10.1002/ibd.20848] [Cited by in Crossref: 145] [Cited by in F6Publishing: 137] [Article Influence: 11.2] [Reference Citation Analysis]
25 Morrison G, Van Langenberg DR, Gibson SJ, Gibson PR. Chronic pain in inflammatory bowel disease: characteristics and associations of a hospital-based cohort. Inflamm Bowel Dis. 2013;19:1210-1217. [PMID: 23524595 DOI: 10.1097/mib.0b013e318280e729] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 4.1] [Reference Citation Analysis]
26 Isaacs KL. How prevalent are extraintestinal manifestations at the initial diagnosis of IBD? Inflamm Bowel Dis. 2008;14 Suppl 2:S198-S199. [PMID: 18816779 DOI: 10.1002/ibd.20597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
27 Dotson JL, Hyams JS, Markowitz J, Leleiko NS, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo D, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-hemker M, Langton CR, Crandall W. Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease and Their Relation to Disease Type and Severity. Journal of Pediatric Gastroenterology & Nutrition 2010;51:140-5. [DOI: 10.1097/mpg.0b013e3181ca4db4] [Cited by in Crossref: 91] [Cited by in F6Publishing: 19] [Article Influence: 7.6] [Reference Citation Analysis]
28 Rezayat F, Hashempur MH, Tavahen H, Salmanroghani H, Emtiazy M. The efficacy of Ramak (a traditional herbal medicine preparation) for patients with ulcerative colitis: A pilot, randomized, triple-blinded, placebo-controlled clinical trial. European Journal of Integrative Medicine 2020;39:101209. [DOI: 10.1016/j.eujim.2020.101209] [Reference Citation Analysis]
29 Naderi N, Farnood A, Habibi M, Zojaji H, Balaii H, Firouzi F, Chiani M, Derakhshan F, Tahami A, Aghazadeh R, Daryani NE, Zali MR. NOD2 exonic variations in Iranian Crohn's disease patients. Int J Colorectal Dis 2011;26:775-81. [PMID: 21274544 DOI: 10.1007/s00384-011-1145-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
30 Malekzadeh F, Alberti C, Nouraei M, Vahedi H, Zaccaria I, Meinzer U, Nasseri-Moghaddam S, Sotoudehmanesh R, Momenzadeh S, Khaleghnejad R, Rashtak S, Olfati G, Malekzadeh R, Hugot JP. Crohn's disease and early exposure to domestic refrigeration. PLoS One 2009;4:e4288. [PMID: 19177167 DOI: 10.1371/journal.pone.0004288] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
31 Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life 2019;12:113-22. [PMID: 31406511 DOI: 10.25122/jml-2018-0075] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
32 Allen PB, Gower-Rousseau C, Danese S, Peyrin-Biroulet L. Preventing disability in inflammatory bowel disease. Therap Adv Gastroenterol. 2017;10:865-876. [PMID: 29147137 DOI: 10.1177/1756283x17732720] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
33 Ko Y, Butcher R, Leong RW. Epidemiological studies of migration and environmental risk factors in the inflammatory bowel diseases. World J Gastroenterol 2014; 20(5): 1238-1247 [PMID: 24574798 DOI: 10.3748/wjg.v20.i5.1238] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
34 Zobeiri M, Bashiri H, Askari L, Keshavars AA, Tavvafzadeh R, Fatahi K, Najafi F. Epidemiologic Characteristics of Patients with Inflammatory Bowel Disease in Kermanshah, Iran. Middle East J Dig Dis. 2017;9:164-169. [PMID: 28894519 DOI: 10.15171/mejdd.2017.68] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
35 Joshaghani H, Amiriani T, Goodarzi R, Mirkarimi H, Besharat S, Roshandel G, Kolasangiani B, Aghili SS; Golestan University of Medical Sciences, Gorgan, Iran, Golestan University of Medical Sciences, Gorgan, Iran, Golestan University of Medical Sciences, Gorgan, Iran, Golestan University of Medical Sciences, Gorgan, Iran, Golestan University of Medical Sciences, Gorgan, Iran, Golestan University of Medical Sciences, Gorgan, Iran, Infectious Disease Research Center, Golestan University of Medical Sciences, Golestan, Iran, Infectious Disease Research Center, Golestan University of Medical Sciences, Golestan, Iran. Serum Concentrations of Trace Elements in Patients with Ulcerative Colitis. jcbr 2018;2:40-5. [DOI: 10.29252/jcbr.2.2.40] [Reference Citation Analysis]
36 El-Tawil AM. Smoking and inflammatory bowel diseases: what in smoking alters the course? Int J Colorectal Dis. 2010;25:671-680. [PMID: 20333390 DOI: 10.1007/s00384-010-0925-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
37 Colombo BB, Fattori V, Guazelli CFS, Zaninelli TH, Carvalho TT, Ferraz CR, Bussmann AJC, Ruiz-Miyazawa KW, Baracat MM, Casagrande R, Verri WA Jr. Vinpocetine Ameliorates Acetic Acid-Induced Colitis by Inhibiting NF-κB Activation in Mice. Inflammation 2018;41:1276-89. [PMID: 29633103 DOI: 10.1007/s10753-018-0776-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
38 Qasim A, Ullah N, Crotty P, Swan N, Breslin N, Ryan B, Torreggiani W, Eguare E, Neary P, O’connor H, O’morain C. A changing trend in the management of patients with newly diagnosed Crohn’s disease. Ir J Med Sci 2011;180:643-7. [DOI: 10.1007/s11845-011-0706-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: Up or down? World J Gastroenterol 2006; 12(38): 6102-6108 [PMID: 17036379 DOI: 10.3748/wjg.v12.i38.6102] [Cited by in CrossRef: 278] [Cited by in F6Publishing: 259] [Article Influence: 17.4] [Reference Citation Analysis]
40 Barberio B, Massimi D, Cazzagon N, Zingone F, Ford AC, Savarino EV. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Gastroenterology 2021:S0016-5085(21)03412-0. [PMID: 34425093 DOI: 10.1053/j.gastro.2021.08.032] [Reference Citation Analysis]
41 Singh B, Kedia S, Konijeti G, Mouli VP, Dhingra R, Kurrey L, Srivastava S, Pradhan R, Makharia G, Ahuja V. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype. Indian J Gastroenterol. 2015;34:43-50. [PMID: 25663290 DOI: 10.1007/s12664-015-0538-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
42 Issa M, Saeian K. Diet in inflammatory bowel disease. Nutr Clin Pract. 2011;26:151-154. [PMID: 21447767 DOI: 10.1177/0884533611400233] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
43 Isaacs KL. How prevalent are extraintestinal manifestations at the initial diagnosis of IBD?: . Inflammatory Bowel Diseases 2008;14:S198-9. [DOI: 10.1097/00054725-200810001-00093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Jajam M, Bozzolo P, Niklander S. Oral manifestations of gastrointestinal disorders. J Clin Exp Dent 2017;9:e1242-8. [PMID: 29167716 DOI: 10.4317/jced.54008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
45 Habibi F, Habibi ME, Gharavinia A, Mahdavi SB, Akbarpour MJ, Baghaei A, Emami MH. Quality of life in inflammatory bowel disease patients: A cross-sectional study. J Res Med Sci 2017;22:104. [PMID: 29026420 DOI: 10.4103/jrms.JRMS_975_16] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
46 Aljebreen AM, Alharbi OR, Azzam NA, Almalki AS, Alswat KA, Almadi MA. Clinical epidemiology and phenotypic characteristics of Crohn's disease in the central region of Saudi Arabia. Saudi J Gastroenterol 2014;20:162-9. [PMID: 24976279 DOI: 10.4103/1319-3767.132993] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
47 Hwangbo Y, Kim HJ, Park JS, Ryu KN, Kim NH, Shim J, Jang JY, Dong SH, Kim BH, Chang YW, Chang R. Sacroiliitis is common in Crohn's disease patients with perianal or upper gastrointestinal involvement. Gut Liver 2010;4:338-44. [PMID: 20981210 DOI: 10.5009/gnl.2010.4.3.338] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
48 Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D, Paoluzi P, Vernia P. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol 2014; 20(46): 17463-17467 [PMID: 25516659 DOI: 10.3748/wjg.v20.i46.17463] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
49 Wang YF, Zhang H, Ouyang Q. Clinical manifestations of inflammatory bowel disease: East and West differences. J Dig Dis. 2007;8:121-127. [PMID: 17650222 DOI: 10.1111/j.1443-9573.2007.00296.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
50 Srinath A, Young E, Szigethy E. Pain management in patients with inflammatory bowel disease: translational approaches from bench to bedside. Inflamm Bowel Dis 2014;20:2433-49. [PMID: 25208108 DOI: 10.1097/MIB.0000000000000170] [Cited by in Crossref: 45] [Cited by in F6Publishing: 21] [Article Influence: 6.4] [Reference Citation Analysis]
51 Bopanna S, Ananthakrishnan AN, Kedia S, Yajnik V, Ahuja V. Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2017;2:269-76. [PMID: 28404156 DOI: 10.1016/S2468-1253(17)30004-3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 32] [Article Influence: 10.2] [Reference Citation Analysis]
52 Wang Y, Ouyang Q; APDW 2004 Chinese IBD working group. Ulcerative colitis in China: Retrospective analysis of 3100 hospitalized patients. J Gastroenterol Hepatol 2007;22:1450-5. [DOI: 10.1111/j.1440-1746.2007.04873.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 4.1] [Reference Citation Analysis]
53 Kröner PT, Lee A, Farraye FA. Respiratory Tract Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:563-74. [PMID: 32448912 DOI: 10.1093/ibd/izaa112] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Goh K, Xiao SD. Inflammatory bowel disease: a survey of the epidemiology in Asia. J Dig Dis 2009;10:1-6. [PMID: 19236540 DOI: 10.1111/j.1751-2980.2008.00355.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 6.0] [Reference Citation Analysis]
55 Zali M, Bahari A, Firouzi F, Daryani NE, Aghazadeh R, Emam MM, Rezaie A, Shalmani HM, Naderi N, Maleki B. Bone mineral density in Iranian patients with inflammatory bowel disease. Int J Colorectal Dis. 2006;21:758-766. [PMID: 16463035 DOI: 10.1007/s00384-005-0084-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
56 Lankarani KB, Sivandzadeh GR, Hassanpour S. Oral manifestation in inflammatory bowel disease: A review. World J Gastroenterol 2013; 19(46): 8571-8579 [PMID: 24379574 DOI: 10.3748/wjg.v19.i46.8571] [Cited by in CrossRef: 88] [Cited by in F6Publishing: 61] [Article Influence: 9.8] [Reference Citation Analysis]
57 Farnood A, Naderi N, Moghaddam SJM, Noorinayer B, Firouzi F, Aghazadeh R, daryani NE, Zali MR. The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis. Int J Colorectal Dis 2007;22:999-1003. [DOI: 10.1007/s00384-007-0270-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
58 Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008;103:3167-82. [PMID: 19086963 DOI: 10.1111/j.1572-0241.2008.02158.x] [Cited by in Crossref: 360] [Cited by in F6Publishing: 364] [Article Influence: 25.7] [Reference Citation Analysis]
59 Sherkat R, Rostami S, Yaran M, Emami MH, Saneian H, Tavakoli H, Adibi P, Behnam M, Sheykhbahaei S, Bagherpour B, Khoshnevisan R, Najafi S. Establishment and Development of the First Biobank of Inflammatory Bowel Disease, Suspected to Primary Immunodeficiency Diseases in Iran. Adv Biomed Res 2018;7:45. [PMID: 29657930 DOI: 10.4103/abr.abr_278_16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Sharif M, Saddique MU, Zahid M, Khan D, Bashir T, Murshed K. Oropharyngeal Candidiasis as a Presenting Symptom of Crohn's Disease. Case Rep Gastroenterol 2020;14:178-85. [PMID: 32399001 DOI: 10.1159/000506931] [Reference Citation Analysis]
61 Srinath AI, Goyal A, Zimmerman LA, Newara MC, Kirshner MA, McCarthy FN, Keljo D, Binion D, Bousvaros A, DeMaso DR. Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients. Inflamm Bowel Dis. 2014;20:1329-1340. [PMID: 24983975 DOI: 10.1097/mib.0000000000000104] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
62 Zeitz J, Ak M, Müller-Mottet S, Scharl S, Biedermann L, Fournier N, Frei P, Pittet V, Scharl M, Fried M. Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account. PLoS One. 2016;11:e0156666. [PMID: 27332879 DOI: 10.1371/journal.pone.0156666] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 8.5] [Reference Citation Analysis]
63 Hosseini SV, Taghavi SA, Jafari P, Rezaianzadeh A, Moini M, Mehrabi M, Sepehrimanesh M, Safarpour AR. Incidence of Ulcerative Colitis Relapse: A Prospective Cohort Study in Southern Iran. Ann Colorectal Res 2016;4. [DOI: 10.17795/acr-34565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Bon L, Scharl S, Vavricka S, Rogler G, Fournier N, Pittet V, Scharl M, Greuter T, Schreiner P, Frei P, Misselwitz B, Biedermann L, Zeitz J; Swiss IBD Cohort Study Group. Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study. PLoS One 2019;14:e0215738. [PMID: 31022217 DOI: 10.1371/journal.pone.0215738] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Tontini GE, Vecchi M, Pastorelli L, Neurath MF, Neumann H. Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives. World J Gastroenterol 2015; 21(1): 21-46 [PMID: 25574078 DOI: 10.3748/wjg.v21.i1.21] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 76] [Article Influence: 13.0] [Reference Citation Analysis]
66 Radmard AR, Haghighi S, Hashemi Taheri AP, Mohammadinejad P, Eftekhar Vaghefi R, Naybandi Atashi S, Pak N, Aghaghazvini L, Malekzadeh R. Magnetic Resonance Enterography in 300 Known Cases of Crohn's Disease: An Initial Report from a Referral Center in Iran. Middle East J Dig Dis 2016;8:273-81. [PMID: 27957290 DOI: 10.15171/mejdd.2016.36] [Reference Citation Analysis]
67 Tozun N, Atug O, Imeryuz N, Hamzaoglu HO, Tiftikci A, Parlak E, Dagli U, Ulker A, Hulagu S, Akpinar H. Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey. J Clin Gastroenterol. 2009;43:51-57. [PMID: 18724251 DOI: 10.1097/mcg.0b013e3181574636] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
68 Baghaei A, Emami MH, Adibi P, Tavakkoli H, Daghaghzadeh H, Tamizifar B, Akbarpour MJ, Hojjatpour B. Inflammatory Bowel Disease Registry and Monitoring: Feasibility Study and Application (Isfahan Inflammatory Bowel Disease Surveillance Project). Int J Prev Med 2019;10:190. [PMID: 31807260 DOI: 10.4103/ijpvm.IJPVM_316_17] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
69 Teimoori-Toolabi L, Samadpoor S, Mehrtash A, Ghadir M, Vahedi H. Among autophagy genes, ATG16L1 but not IRGM is associated with Crohn's disease in Iranians. Gene 2018;675:176-84. [PMID: 29960072 DOI: 10.1016/j.gene.2018.06.074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
70 Alarhayem A, Achebe E, Logue AJ. Psychosocial Support of the Inflammatory Bowel Disease Patient. Surgical Clinics of North America 2015;95:1281-93. [DOI: 10.1016/j.suc.2015.08.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
71 Fedor I, Zold E, Barta Z. Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease. J Clin Med 2021;10:5984. [PMID: 34945280 DOI: 10.3390/jcm10245984] [Reference Citation Analysis]
72 Nóbrega VG, Silva INN, Brito BS, Silva J, Silva MCMD, Santana GO. THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS. Arq Gastroenterol 2018;55:290-5. [PMID: 30540094 DOI: 10.1590/S0004-2803.201800000-73] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
73 Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2011;7:235-241. [PMID: 21857821 DOI: 10.1007/978-3-319-26811-8_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Chiurillo MA. Can the prevalence of symptoms in patients with inflammatory bowel disease be predicted by the analysis of multidrug resistance gene 1 polymorphisms? Saudi J Gastroenterol 2013;19:139-40. [PMID: 23828741 DOI: 10.4103/1319-3767.114502] [Reference Citation Analysis]
75 Ghanadi K, Valizadeh J, Hasanvand A. Epidemiological and clinical aspects of ulcerative colitis in west of Iran: a cross sectional study. Springerplus 2016;5:1588. [PMID: 27652161 DOI: 10.1186/s40064-016-3248-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]